Feedback plc
Vertex In Healthcare collaboration to further international
expansion
Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the clinical infrastructure specialist,
announces a collaboration agreement ("Agreement") with Vertex In
Healthcare ("Vertex"), a specialist clinical IT firm with offices
in the UK, UAE and South Africa, to combine key technologies and
resell each other's products with a view to driving commercial
opportunities in multiple markets. The Agreement enables the
companies to work together and outlines the key terms which will
form the basis of definitive commercial agreements for multiple
collaborations.
Broadened product functionality to strengthen global
reach
Vertex is the UK registered reseller
of the MedDream medical image viewer, an advanced diagnostics web
viewer manufactured by UAB Softneta, which has existing regulatory
approval (FDA Cleared and CE Marked) in a number of territories
including the USA, Middle East and Europe.
The Agreement will enable Feedback to
incorporate the MedDream viewer into Bleepa, enabling Bleepa to be
sold directly to Radiologists for primary diagnostic reporting
services, strengthening the Company's teleradiology offering and
expanding the reach of the product to new territories such as the
USA.
Embedding a viewer with existing
regulatory approval in multiple international territories will
enable the combined Bleepa/MedDream product to meet the regulatory
requirements to be sold directly into these markets. Although the
Company's primary international focus remains on its growing
opportunity in India, this collaboration gives the Company the
potential to expand into a number of key international territories
as opportunities present themselves, most notably in the USA and
Middle East.
The Agreement will position Feedback
and Vertex to resell each other's products in multiple territories,
allowing both entities to expand more rapidly and cost effectively
into regions where the other has an existing footprint. Bleepa
offers considerable value and product differentiation to Vertex's
existing solutions in their current markets and will enable them to
grow market share across multiple customer segments.
Opportunity to drive revenues from Cadran
As part of the Agreement, Vertex will
licence the database capabilities of Feedback's legacy picture
archiving communication system Cadran PACS, now with the MedDream
Viewer, which will allow it to build a PACS proposition that will
initially be sold in South Africa and other international markets
including the UK, where it sells PACS. This is another example of
the Company's strategy to generate licencing royalties from its
legacy products.
The Agreement covers a number of
confidential commercial terms depending on the specific
collaborative arrangement. Although no minimum targets are
required, both companies are motivated to achieve high levels of
commercialisation as a result of this Agreement.
Dr
Tom Oakley, CEO Feedback plc said: "Vertex is a great partner for Feedback. Like us it is
commercially minded, ambitious and on a clear mission to improve
healthcare. Our products naturally fit together and create a
compelling value proposition to customers, especially those who are
increasingly looking for the most streamlined and cost-effective
way of procuring the solutions that they need. Incorporating the
MedDream viewer into Bleepa opens up new opportunities for us, both
domestically to Radiologists and internationally, allowing us to
expand more rapidly if we see opportunities overseas, avoiding some
of the difficulties that we had in registering Bleepa as a medical
device directly in India."
Chris Goldie, CEO of Vertex In Healthcare said:
"Bleepa is a fantastic tool that presents a real
value add to our customers and will help us to differentiate
ourselves in the market. The addition of Cadran PACS to our
portfolio will allow us to offer a full product suite to customers,
making us the go-to supplier for a complete hospital IT solutions.
We are excited about the potential of this partnership and look
forward to growing together."
--Ends--
Enquiries:
Feedback plc
Tom Oakley, CEO
Anesh Patel, CFO
|
+44 (0) 20 3997 7634
IR@fbk.com
|
|
|
Panmure Liberum Limited (NOMAD and Broker)
Emma Earl/Freddy Crossley/Mark
Rogers (Corporate Finance)
Rupert Dearden (Corporate
Broking)
|
+44 (0)20 7886 2500
|
|
|
Walbrook PR Ltd;
|
Tel: 020 7933 8780 or
feedbackplc@walbrookpr.com
|
Nick Rome/Joe Walker
|
07748 325 236 or 07407 020
470
|
About Feedback
Feedback plc helps clinical teams to
make better decisions faster for patients. We design products that
enhance clinician access to patient data and to their colleagues.
Our unique approach centres around individual patient episodes,
into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a
result, we produce a digital infrastructure that makes patient data
available to clinicians in multiple settings, in a format that
enables them to meaningfully interact with it, providing
flexibility to clinicians and free movement of patients between
provider settings - clinicians can practice from anywhere and
patients can attend any care provider for
treatment.
Our products Bleepa and CareLocker
work together to deliver unparalleled value to our customers.
Bleepa is our application layer and sits on top of CareLocker as
our data layer. Bleepa is a clinician facing platform that displays
clinical results from a patient's CareLocker at a certified and
regulated quality, that is suitable for clinical use and enables
dialogue on a patient-by-patient basis with colleagues through a
secure, auditable chat interface that links back to the patient
medical record. The CareLocker data storage model is built around
the patient. Our vision is one where relevant clinical data is
always available to the patient as well as to any care setting that
they may attend - a federated data architecture with the patient as
the tenant.
The Company has a number of growth
opportunities domestically and internationally across a range of
markets including the NHS, the veterinary market and private
healthcare providers and its highly scalable Software as a Service
("SaaS")-based model is expected to provide increasing levels of
revenue visibility as the Company grows its customer
base.